托西利祖马布和电解质失衡:严重的低血导致
İrada İbramkhalilova1, Fatih Demir2, Zeynel Abidin Sayiner3
1Department of Rheumatology, SANKO University, Gaziantep, Turkey.
BMJ case reports
|September 18, 2025
概括
托西利祖马布是一种IL-6受体对抗剂,很少会导致严重的低血量和. 这一案例凸显了在接受托西利祖马布治疗炎症病症的患者中监测水平的重要性.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 托西利祖马布是一种介素-6 (IL-6) 受体对抗剂,用于治疗类风湿性关节炎和成人始发的斯蒂尔病 (AOSD) 等炎症性疾病.
- 常见的副作用包括过敏,中性质减退和肝功能障碍.
- 低血是一种罕见但严重的不良反应.
研究的目的:
- 报告一种罕见的严重低血和急性性的病例,该病例发生在接受tocilizumab治疗的患者身上.
- 调查IL-6抑制与平衡中断之间的潜在联系.
主要方法:
- 一个30多岁的男性患者的病例报告,患有AOSD.
- 电解质水平的监测,心电图和神经成像 (大脑和脊髓MRI).
主要成果:
- 患者在第三次托西利祖马布输液后出现严重的低血 (2.0 mmol/L) 和急性性.
- 电心电图显示U波和轻微的QT延长.
- 替代治疗导致在24小时内完全康复.
结论:
- 干白素-6 (IL-6) 抑制可能会破坏平衡,可能导致低血.
- 在托西利祖马布治疗期间突然的患者应考虑低血清症.
- 这一案例强调了需要对免疫调节疗法的罕见不良影响保持警.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
776
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
776
Depolarizing Blockers: Mechanism of Action
2.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.7K
Antiepileptic Drugs: Potassium Channel Activators
635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
635
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Classification of Skeletal Muscle Relaxants
3.1K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.1K
Chronic Kidney Disease II: Clinical Manifestations
557
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
557


